News

Abzena, the leading end-to-end integrated CDMO for complex biologic molecules and Antibody Drug Conjugates (ADCs) has announced the appointment of Sean O’Brien as Senior Vice President and Site Head at its San Diego facility. Sean will be responsible for leading...

A study has gone on to find that monoclonal antibodies (mAbs) decreased the risk of hospitalisation or even death by 39% if given within two days to people who are tested positive for COVID-19. The research compared the patients who...

For the very first time, drug research participants can go on to give digital consent when it comes to their participation. This will take place in the first study that will happen in all Dutch general practitioner practises partnered...

Researchers from the University of Queensland in Australia have led a national study pertaining to four major bacteria that cause sepsis, thereby providing new targets when it comes to developing antibiotics. Professor Mark Schembri and Professor Mark Walker from the...

A novel artificial intelligence tool can help predict the functions of enzymes on the basis of their amino acid sequences, even when the enzymes are unstudied or not clearly understood. As per the researchers, the AI tool called CLEAN outshines...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and the Government of the Republic of Kenya have finalized an agreement to establish an mRNA manufacturing facility in the Republic of Kenya. This will be the...

Galapagos NV entered into a strategic collaboration with NovAliX in which Galapagos’ research and discovery capabilities and exclusively related employees based in Romainville, France, will be transferred to NovAliX, a drug discovery-focused contract research organization (CRO). The agreement follows Galapagos’...